Pacritinib Metabolite M2

Details

Stereochemistry	ACHIRAL
Molecular Formula	C22H21N3O3
Molecular Weight	375.4204
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OC1=CC=C2C=C1COC\C=C\COCC3=CC(=CC=C3)C4=CC=NC(N4)=N2

InChI

InChIKey=UVANEUUATLLBKA-OWOJBTEDSA-N

InChI=1S/C22H21N3O3/c26-21-7-6-19-13-18(21)15-28-11-2-1-10-27-14-16-4-3-5-17(12-16)20-8-9-23-22(24-19)25-20/h1-9,12-13,26H,10-11,14-15H2,(H,23,24,25)/b2-1+

HIDE SMILES / InChI

Molecular Formula	C22H21N3O3
Molecular Weight	375.4204
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 19:31:19 UTC 2023` Edited by `admin` on `Sat Dec 16 19:31:19 UTC 2023`
Record UNII	UD78C37Y28
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Pacritinib Metabolite M2

Common Name

English

14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaen-11-ol, (16E)-

Systematic Name

English

SB-2403

Code

English

(16E)-14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaen-11-ol

Systematic Name

English

Code System Code Type Description

CAS

1312603-69-2

Created by admin on Sat Dec 16 19:31:19 UTC 2023 , Edited by admin on Sat Dec 16 19:31:19 UTC 2023

PRIMARY

PUBCHEM

53364338

Created by admin on Sat Dec 16 19:31:19 UTC 2023 , Edited by admin on Sat Dec 16 19:31:19 UTC 2023

PRIMARY

FDA UNII

UD78C37Y28

Created by admin on Sat Dec 16 19:31:19 UTC 2023 , Edited by admin on Sat Dec 16 19:31:19 UTC 2023

PRIMARY

Related Record Type Details


					G22N65IL3O

PACRITINIB

PARENT -> METABOLITE LESS ACTIVE

Comments:

Predominant Metabolite in human studies

Interaction Type:

MAJOR

Qualification:

FECAL; PLASMA; URINE

Amount: